SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001159036-20-000030
Filing Date
2020-05-11
Accepted
2020-05-11 16:09:12
Documents
75
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q haloq120-10q.htm   iXBRL 10-Q 1448740
2 EXHIBIT 31.1 ex31110qq12020.htm EX-31.1 17448
3 EXHIBIT 31.2 ex31210qq12020.htm EX-31.2 17475
4 EXHIBIT 32 ex3210qq12020.htm EX-32 20695
10 slide1b16.jpg GRAPHIC 389941
11 slide2b05.jpg GRAPHIC 299543
  Complete submission text file 0001159036-20-000030.txt   8951660

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT halo-20200331.xsd EX-101.SCH 45603
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT halo-20200331_cal.xml EX-101.CAL 86558
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT halo-20200331_def.xml EX-101.DEF 230367
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT halo-20200331_lab.xml EX-101.LAB 641119
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT halo-20200331_pre.xml EX-101.PRE 390300
44 EXTRACTED XBRL INSTANCE DOCUMENT haloq120-10q_htm.xml XML 1283666
Mailing Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345
Business Address 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121-1345 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Filer) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32335 | Film No.: 20864840
SIC: 2836 Biological Products, (No Diagnostic Substances)